BioCentury
ARTICLE | Clinical News

JVRS-100: Phase II started

November 2, 2009 8:00 AM UTC

Juvaris began a double-blind Phase II trial to compare Fluzone with or without 3.75, 7.5 or 25 ug of intramuscular JVRS-100 adjuvant in about 472 elderly volunteers. Fluzone is a trivalent influenza ...